BioSpace News Archive

Genetown

Ribon Therapeutics to Present at Upcoming Healthcare Conferences in May 2020

Ribon Therapeutics announced that Victoria Richon, Ph.D., President and CEO, will present at two upcoming virtual healthcare conferences. Presentations will consist of a panel discussion and a corporate overview..

May 4, 2020
·
1 min read
Drug Development

Mallinckrodt Announces Positive Findings in INOmax® (Nitric Oxide) Gas, for Inhalation Phase 4 Observational Registry in Neonates with Pulmonary Hypertension; Ends Trial Early

Company ends Phase 4 observational registry early as data achieved statistical significance for non-inferiority in premature neonates compared to term and near-term neonates at planned interim analysis

May 4, 2020
·
9 min read
Business

Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate

Anixa Biosciences, Inc., a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, announced that it, with partner OntoChem GmbH, has identified its first therapeutic candidate against Covid-19, and has advanced the compound into biological testing.

May 4, 2020
·
5 min read
ITC Judge’s Initial Determination Rejects Align Technology Claims against the 3Shape TRIOS scanner

3Shape announced that the company has received a favorable Notice of Initial Determination regarding the 3Shape TRIOS scanner.

May 4, 2020
·
2 min read
Business

VBL Therapeutics to Report First Quarter 2020 Financial Results on May 14

VBL Therapeutics announced that it will host a conference call and live audio webcast on Thursday, May 14, 2020 at 8:30am Eastern Time to report first quarter ended March 31, 2020 financial results and to provide a corporate update.

May 4, 2020
·
1 min read
Deals

Centene To Invest In Critical Mental Health Resources

Centene partners with organizations across the country to support their respective mental health efforts during COVID-19 pandemic

May 4, 2020
·
12 min read
Business

Protagonist Therapeutics to Announce First Quarter 2020 Financial Results and Provide Corporate and R&D Update

Protagonist Therapeutics, Inc. will announce first quarter financial results after the NASDAQ market closes on Thursday, May 7, 2020.

May 4, 2020
·
2 min read
Biotech Bay

Nevro To Participate in Upcoming May 2020 Conferences

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that Nevro Chairman, CEO and President D. Keith Grossman is scheduled to speak at the following upcoming virtual investor conferences:.

May 4, 2020
·
1 min read
Business

ALX Oncology Announces Appointment of Rekha Hemrajani to Board of Directors

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, announced the appointment of Rekha Hemrajani to its Board of Directors.

May 4, 2020
·
2 min read
Pharm Country

Newron Reports Top-Line Results From Its STARS Study Evaluating Sarizotan in Patients With Rett Syndrome

Newron will prioritize its Phase III development program of Evenamide in schizophrenia and evaluate additional pipeline candidates

May 4, 2020
·
7 min read